2023
DOI: 10.1097/pr9.0000000000001112
|View full text |Cite
|
Sign up to set email alerts
|

The effect of psychological factors on pain outcomes: lessons learned for the next generation of research

Geert Crombez,
Elke Veirman,
Dimitri Van Ryckeghem
et al.

Abstract: Big data and machine learning techniques offer opportunities to investigate the effects of psychological factors on pain outcomes. Nevertheless, these advances can only deliver when the quality of the data is high and the underpinning causal assumptions are considered. We argue that there is room for improvement and identify some challenges in the evidence base concerning the effect of psychological factors on the development and maintenance of chronic pain. As a starting point, 3 basic tenets of causality are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 89 publications
0
3
0
Order By: Relevance
“…In the realm of VR technology, the patient’s attention is captivated by a simulated computer world. Given the brain’s limitations in processing information, this technique triggers a flood of multi-sensory information to be processed simultaneously; this in turn diminishes the patient’s focus on painful signals, thereby alleviating the sensation of pain 52 – 54 .…”
Section: Discussionmentioning
confidence: 99%
“…In the realm of VR technology, the patient’s attention is captivated by a simulated computer world. Given the brain’s limitations in processing information, this technique triggers a flood of multi-sensory information to be processed simultaneously; this in turn diminishes the patient’s focus on painful signals, thereby alleviating the sensation of pain 52 – 54 .…”
Section: Discussionmentioning
confidence: 99%
“…Based on the timeframe between exposure and outcome, psychosocial factors can act as predisposing, precipitating, and maintaining factors [3]. We need studies to track changes in psychosocial factors over time, uncovering the relationships between each other and exploring the underlying factors that predict these changes and how they influence outcome.…”
Section: Where Do We Need To Go?mentioning
confidence: 99%
“…These CDS tools should be (1) validated, ideally in combination between content experts and individuals with lived experiences; (2) culturally contextualized, that is easily understood by the local population of interest; and (3) feasible to be used in a busy, routine, clinical setting that is ideally linked to the electronic medical health records. Artificial intelligence and machine learning are powerful tools that if used correctly, can complement this effort by processing large volumes of high-quality data [3] to develop predictive algorithms. These algorithms must be rigorously tested and validated in local populations through the use of training and validation datasets, with their performance evaluated continuously through their realworld implementation.…”
Section: Where Do We Need To Go?mentioning
confidence: 99%
“…These controls serve as an indispensable tool in conducting randomized controlled trials (RCTs), providing a baseline to determine whether a treatment outperforms the placebo or proves ineffective [ 88 ]. In the context of chronic pain, where conscious expectation has proven unreliable in predicting placebo effects, the need for rigorous placebo-controlled trials becomes even more evident [ 91 ].…”
Section: Reviewmentioning
confidence: 99%
“…Addressing this observed phenomenon, Harvard professor Ted Kaptuck delved into the realm of uncertainty and deception, aiming to unravel their necessity in eliciting placebo effects [ 90 ]. Double-blind RCTs, widely considered the gold standard, introduce uncertainty by informing the patient, "You may receive the drug or placebo" [ 91 ]. Kaptuck's research yielded fascinating insights, revealing that the mere prospect of receiving the drug led to increased positive responses among pain patients [ 92 ].…”
Section: Reviewmentioning
confidence: 99%